Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014896
Filing Date
2024-11-07
Accepted
2024-11-07 16:56:56
Documents
105
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cyrx-20240930x10q.htm   iXBRL 10-Q 2733909
2 EX-31.1 cyrx-20240930xex31d1.htm EX-31.1 14267
3 EX-31.2 cyrx-20240930xex31d2.htm EX-31.2 13153
4 EX-32.1 cyrx-20240930xex32d1.htm EX-32.1 17263
5 GRAPHIC cyrx-20240930x10q004.jpg GRAPHIC 8145
  Complete submission text file 0001558370-24-014896.txt   12612299

Data Files

Seq Description Document Type Size
6 EX-101.SCH cyrx-20240930.xsd EX-101.SCH 75292
7 EX-101.CAL cyrx-20240930_cal.xml EX-101.CAL 101347
8 EX-101.DEF cyrx-20240930_def.xml EX-101.DEF 314067
9 EX-101.LAB cyrx-20240930_lab.xml EX-101.LAB 669066
10 EX-101.PRE cyrx-20240930_pre.xml EX-101.PRE 537032
108 EXTRACTED XBRL INSTANCE DOCUMENT cyrx-20240930x10q_htm.xml XML 2629939
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34632 | Film No.: 241436828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)